IL4 and breast carcinoma: M2 macrophage infiltration assays indicated that PAZ@Fe-MOF treatment significantly decreased the infiltration of IL-4/IL-13-stimulated THP-1 cells (M2-like macrophages) into breast cancer tissues (Fig. 5E-F).